Fig. 4 | Signal Transduction and Targeted Therapy

Fig. 4

From: Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity

Fig. 4

A model for the BCMA–NbT complex. a Superposition of the Nb1 and the Nb2 complexes based on BCMAECD. The secondary interface observed in the Nb1–BCMAECD structure is omitted for clarity. b Nanobody epitopes mapped on the BCMAECD surface. Residues in contact with Nb1 are outlined in blue while those in contact with Nb2 in yellow. c Competition for BCMA binding between Nb1 and Nb2 assayed using SPR. Fc-tagged human BCMAECD was immobilized onto a Protein A sensor chip as the ligand. Nb1 (2000 nM) or Nb2 (100 nM) was loaded with BCMAECD-Fc for 1 min, followed by a mixture of Nb1 (2000 nM) and Nb2 (100 nM). d Small-angle X-ray scattering (SAXS) envelopes and corresponding models of Nb1 (left), Nb2 (middle), and NbT (right) based on the crystal structures of the Nb1–BCMAECD and the Nb2–BCMAECD complexes

Back to article page